Eleven Biotherapeutics, Inc. (EBIO) - NASDAQ
  • wilkinson99 | Send Message 27 Jun

    Top % Losers: $AVOP -32%, $BCS -23%, $EMES -17%, $LYG -16%, $TRXC -15% $ORIG $CJES $LGCY $RBS $RYAAY $EBIO $VMEM $LABU $SOXL $EURL $EVR $GST
    Reply
      • Alexander Valtsev | Send Message 24 Jun

        Buy with strong upside price movement prevails. Trade in the right direction: http://bit.ly/240616EBIO $EBIO
        Reply
          • wilkinson99 | Send Message 22 Jun

            Premarket Top % Gainers: $SPU 65% (only 10K volume) $SUNW 16%, $SCTY 12%, $PSTI 10%, $NVCN 9%, $ECTE 7%, $WGO $OCN $EBIO $PBMD $MPET $DELT
            Reply
              • wilkinson99 | Send Message 22 Jun

                Premarket Top % Gainers: $SCTY 16%, $NVCN 16%, $PSTI 10%, $BCEI 9%, $EBIO 7%, $WGO 6% $SGY $SBGL $ERX $VALE $DGAZ $IAG $MRO $NUGT $PSO $CHK
                Reply
                  • Colin Macleod | Send Message 17 Jun

                    $EBIO - ElevenBio Therapuetics - Independent Analysis http://tinyurl.com/jrdl6fu
                    Reply
                      • timtrading | Send Message 16 Jun
                        Reply
                          • Colin Macleod | Send Message 15 Jun

                            Greatstockpix Watch List Video for June 16th Error $SPY $JAGX $MTCH $SWHC $GBIM $EBIO $LBIX $JD $CLRB $WFM $MGT
                            Reply
                              • Colin Macleod | Send Message 14 Jun

                                Greatstockpix Watch List Video for June 15th http://bit.ly/1PsNLnf $MTCH $BSPM $EXAS $GBIM $GBR $SWHC $EBIO $PAY $JAGX $MGT $LBIX
                                Reply
                                  • timothy russell | Send Message 14 Jun

                                    $EBIO lol.. Beautiful drop straight down
                                    Reply
                                      • timtrading | Send Message 13 Jun
                                        Reply
                                          Company Description
                                          Eleven Biotherapeutics, Inc. is a preclinical stage biopharmaceutical company with a proprietary protein engineering platform, called AMP-Rx, that it apply to the discovery and development of protein therapeutics to treat diseases of the eye. Its therapeutic approach is based on the role of... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States